Pharmacokinetics, mass balance, and metabolism of [14C]envonalkib (TQ-B3139), a novel ALK tyrosine kinase inhibitor, in healthy Chinese subjects
ConclusionEnvonalkib was extensively metabolized prior to excretion and eliminated primarily as metabolites via feces.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | China Health | Drugs & Pharmacology | Lung Cancer | Lymphoma | Non-Small Cell Lung Cancer | Oral Cancer | Study